These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1605652)

  • 21. Clinical relevance of different sequencing of doxorubicin and cyclophosphamide, methotrexate, and Fluorouracil in operable breast cancer.
    Bonadonna G; Zambetti M; Moliterni A; Gianni L; Valagussa P
    J Clin Oncol; 2004 May; 22(9):1614-20. PubMed ID: 15117983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinoma.
    Mikhak B; Zahurak M; Abeloff MD; Fetting JH; Davidson NE; Donehower RC; Waterfield W; Kennedy MJ
    Cancer; 1999 Feb; 85(4):899-904. PubMed ID: 10091768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol INT-0102.
    Hutchins LF; Green SJ; Ravdin PM; Lew D; Martino S; Abeloff M; Lyss AP; Allred C; Rivkin SE; Osborne CK
    J Clin Oncol; 2005 Nov; 23(33):8313-21. PubMed ID: 16293862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: long-term results].
    Conti F; Carpano S; Sergi D; Di Lauro L; Amodio A; Vici P; Abbate MI; Ferranti FR; Viola G; Botti C; Foggi P; Sperduti I; Lopez M
    Clin Ter; 2007; 158(4):331-41. PubMed ID: 17953285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant chemotherapy in breast cancer.
    Del Mastro L; Costantini M; Bianco AR
    N Engl J Med; 1995 Aug; 333(9):596; author reply 597. PubMed ID: 7623914
    [No Abstract]   [Full Text] [Related]  

  • 26. Epirubicin chemotherapy and advanced breast cancer after adjuvant CMF chemotherapy.
    Bissett D; Paul J; Wishart G; Jodrell D; Machan MA; Harnett A; Canney P; George WD; Kaye S
    Clin Oncol (R Coll Radiol); 1995; 7(1):12-5. PubMed ID: 7727299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chemotherapy of cancer of the breast].
    de la Garza Salazar JG
    Ginecol Obstet Mex; 1977 Oct; 42(252):237-45. PubMed ID: 401388
    [No Abstract]   [Full Text] [Related]  

  • 28. Metastatic breast cancer and its complications.
    Rubens RD
    Curr Opin Oncol; 1992 Dec; 4(6):1050-4. PubMed ID: 1457519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction chemotherapy and intensification with autologous bone marrow reinfusion in patients with locally advanced and disseminated breast cancer.
    Mulder NH; Mulder PO; Sleijfer DT; Willemse PH; van der Ploeg E; Dolsma WV; de Vries EG
    Eur J Cancer; 1993; 29A(5):668-71. PubMed ID: 8471323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination chemotherapy and systemic irradiation consolidation for poor prognosis breast cancer.
    Livingston RB; Schulman S; Griffin BR; Tranum BL; Rivkin SE; Goldberg RS; Fabian CJ; Hammond N; Hynes H
    Cancer; 1987 Apr; 59(7):1249-54. PubMed ID: 3545430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination chemotherapy and high-dose cyclophosphamide intensification for poor prognosis breast cancer. A Southwest Oncology Group Study.
    Ellis GK; Green S; Schulman S; Tranum BL; Goldberg RS; Livingston RB
    Cancer; 1989 Dec; 64(12):2409-15. PubMed ID: 2684382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant chemo-hormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate for node-positive cancer patients. Update at 7-year follow-up.
    Hupperets P; Wils J; Volovics L; Schouten L; Fickers M; Bron H; Schouten H; Jager J; de Jong J; Beex L
    Ann Oncol; 1995 Jan; 6(1):90-1. PubMed ID: 7710989
    [No Abstract]   [Full Text] [Related]  

  • 33. A randomized comparison of cyclophosphamide, Adriamycin, and 5-fluorouracil with triethylenethiophosphoramide and methotrexate, both as sequential and as fixed rotational treatment in patients with advanced ovarian cancer.
    Bruckner HW; Dinse GE; Davis TE; Falkson G; Creech RH; Arseneau JC; Greenspan EM; Brodovsky HS; Pagano M; Hahn RG
    Cancer; 1985 Jan; 55(1):26-40. PubMed ID: 3917352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New adjuvant trials for resectable breast cancer at the Istituto Nazionale Tumori of Milan.
    Bonadonna G; Bignami P; Buzzoni R; Moliterni A; Valagussa P; Veronesi U
    Recent Results Cancer Res; 1984; 91():210-3. PubMed ID: 6374799
    [No Abstract]   [Full Text] [Related]  

  • 35. Doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil for breast cancer.
    Michaelsoln RA
    JAMA; 1995 Sep; 274(10):796-7. PubMed ID: 7650797
    [No Abstract]   [Full Text] [Related]  

  • 36. Taxane-based chemotherapy for node-positive breast cancer--take-home lessons.
    Ellis M
    N Engl J Med; 2010 Jun; 362(22):2122-4. PubMed ID: 20519684
    [No Abstract]   [Full Text] [Related]  

  • 37. Chemotherapy is a safe and effective initial therapy for infected malignant breast and chest wall ulcers.
    Dauphin S; Katz S; el Tamer M; Wait R; Sohn C; Braverman AS
    J Surg Oncol; 1997 Nov; 66(3):186-8. PubMed ID: 9369964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term complete remission of stage IV breast cancer after high-dose chemotherapy and autologous bone marrow transplantation.
    Dunphy FR; Spitzer G
    Am J Clin Oncol; 1990 Aug; 13(4):364-6. PubMed ID: 2165740
    [No Abstract]   [Full Text] [Related]  

  • 39. Invited commentary: The impact of neoadjuvant chemotherapy on patients with locally advanced breast cancer in a nigerian semiurban teaching hospital: a single-center descriptive study.
    Buccimazza I
    World J Surg; 2010 Aug; 34(8):1779-81. PubMed ID: 20467743
    [No Abstract]   [Full Text] [Related]  

  • 40. Advanced primary breast cancer: assessment at mammography of response to induction chemotherapy.
    Segel MC; Paulus DD; Hortobagyi GN
    Radiology; 1988 Oct; 169(1):49-54. PubMed ID: 3420282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.